반응식
Br[C:2]1[CH:7]=[CH:6][C:5]([S:8]([NH:11][C:12]2[CH:17]=[C:16]([N:18]3[CH2:23][C@H:22]([CH3:24])[NH:21][C@H:20]([CH3:25])[CH2:19]3)[CH:15]=[CH:14][C:13]=2[O:26][CH3:27])(=[O:10])=[O:9])=[CH:4][CH:3]=1.[NH:28]1[CH2:32][CH2:31][CH2:30][C:29]1=[O:33]>>[CH3:25][C@H:20]1[NH:21][C@@H:22]([CH3:24])[CH2:23][N:18]([C:16]2[CH:15]=[CH:14][C:13]([O:26][CH3:27])=[C:12]([NH:11][S:8]([C:5]3[CH:6]=[CH:7][C:2]([N:28]4[CH2:32][CH2:31][CH2:30][C:29]4=[O:33])=[CH:3][CH:4]=3)(=[O:10])=[O:9])[CH:17]=2)[CH2:19]1참가 물질
3
실험 절차
The title compound (E121) was prepared from 4-bromo-N-[5-(cis-3,5-dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]benzenesulfonamide (E106) and 2-pyrrolidinone using a similar method to that described for Example 23 (E23). MS (ES+) m/e 459 [M+H]+.
출처 및 근거
- ORD 기록
- ord-a5606477bb37401f89c5a5b3faebfc91
- 출처 데이터셋
- uspto-grants-2008_06
- 특허 번호
- US07381728B2
연결된 노트
불러오는 중…